767 related articles for article (PubMed ID: 8284673)
21. Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis.
Mdluli K; Sherman DR; Hickey MJ; Kreiswirth BN; Morris S; Stover CK; Barry CE
J Infect Dis; 1996 Nov; 174(5):1085-90. PubMed ID: 8896513
[TBL] [Abstract][Full Text] [Related]
22. Fast-growing, non-infectious and intracellularly surviving drug-resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening.
Gupta A; Bhakta S; Kundu S; Gupta M; Srivastava BS; Srivastava R
J Antimicrob Chemother; 2009 Oct; 64(4):774-81. PubMed ID: 19656786
[TBL] [Abstract][Full Text] [Related]
23. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex.
Wilson TM; Collins DM
Mol Microbiol; 1996 Mar; 19(5):1025-34. PubMed ID: 8830260
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.
Musser JM; Kapur V; Williams DL; Kreiswirth BN; van Soolingen D; van Embden JD
J Infect Dis; 1996 Jan; 173(1):196-202. PubMed ID: 8537659
[TBL] [Abstract][Full Text] [Related]
25. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis].
Rueda J; Realpe T; Mejía G; Zapata E; Robledo J
Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis.
Quémard A; Sacchettini JC; Dessen A; Vilcheze C; Bittman R; Jacobs WR; Blanchard JS
Biochemistry; 1995 Jul; 34(26):8235-41. PubMed ID: 7599116
[TBL] [Abstract][Full Text] [Related]
27. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of InhA activity, but not KasA activity, induces formation of a KasA-containing complex in mycobacteria.
Kremer L; Dover LG; Morbidoni HR; Vilchèze C; Maughan WN; Baulard A; Tu SC; Honoré N; Deretic V; Sacchettini JC; Locht C; Jacobs WR; Besra GS
J Biol Chem; 2003 Jun; 278(23):20547-54. PubMed ID: 12654922
[TBL] [Abstract][Full Text] [Related]
29. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis.
Heym B; Alzari PM; Honoré N; Cole ST
Mol Microbiol; 1995 Jan; 15(2):235-45. PubMed ID: 7746145
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.
Parikh SL; Xiao G; Tonge PJ
Biochemistry; 2000 Jul; 39(26):7645-50. PubMed ID: 10869170
[TBL] [Abstract][Full Text] [Related]
31. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
[TBL] [Abstract][Full Text] [Related]
32. Overproduction of mycobacterial ribosomal protein S13 induces catalase/peroxidase activity and hypersensitivity to isoniazid in Mycobacterium smegmatis.
Dubnau E; Soares S; Huang TJ; Jacobs WR
Gene; 1996 Apr; 170(1):17-22. PubMed ID: 8621083
[TBL] [Abstract][Full Text] [Related]
33. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains.
Ristow M; Möhlig M; Rifai M; Schatz H; Feldmann K; Pfeiffer A
Lancet; 1995 Aug; 346(8973):502-3. PubMed ID: 7637495
[No Abstract] [Full Text] [Related]
34. Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.
Bollela VR; Namburete EI; Feliciano CS; Macheque D; Harrison LH; Caminero JA
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1099-104. PubMed ID: 27393546
[TBL] [Abstract][Full Text] [Related]
35. Novel selection for isoniazid (INH) resistance genes supports a role for NAD+-binding proteins in mycobacterial INH resistance.
Chen P; Bishai WR
Infect Immun; 1998 Nov; 66(11):5099-106. PubMed ID: 9784509
[TBL] [Abstract][Full Text] [Related]
36. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid.
Deretic V; Philipp W; Dhandayuthapani S; Mudd MH; Curcic R; Garbe T; Heym B; Via LE; Cole ST
Mol Microbiol; 1995 Sep; 17(5):889-900. PubMed ID: 8596438
[TBL] [Abstract][Full Text] [Related]
37. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
Rozwarski DA; Grant GA; Barton DH; Jacobs WR; Sacchettini JC
Science; 1998 Jan; 279(5347):98-102. PubMed ID: 9417034
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.
Lavender C; Globan M; Sievers A; Billman-Jacobe H; Fyfe J
Antimicrob Agents Chemother; 2005 Oct; 49(10):4068-74. PubMed ID: 16189082
[TBL] [Abstract][Full Text] [Related]
39. Thermodynamic integration combined with molecular dynamic simulations to explore the cross-resistance mechanism of isoniazid and ethionamide.
Zhang Q; Yang Y; Gong X; Zhao N; Zhang Y; Liu H
Proteins; 2022 May; 90(5):1142-1151. PubMed ID: 34981576
[TBL] [Abstract][Full Text] [Related]
40. Precise null deletion mutations of the mycothiol synthesis genes reveal their role in isoniazid and ethionamide resistance in Mycobacterium smegmatis.
Xu X; Vilchèze C; Av-Gay Y; Gómez-Velasco A; Jacobs WR
Antimicrob Agents Chemother; 2011 Jul; 55(7):3133-9. PubMed ID: 21502624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
